Investor Presentation • Mar 20, 2019
Investor Presentation
Open in ViewerOpens in native device viewer
STAR Conference – Milan March 20th, 21st 2019
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
Hi-Tech industrial group active in opto-electronics with proprietary technologies and know how developed over 35 years
Listed on the Milan Stock Exchange Star segment since 2000
More than 20 companies active worldwide on several laser application segments and markets
Progressively widening its worldwide presence registering continuous growth over the years More than 45,000 laser sources sold and 5% of revenue invested in R&DMore than 120 patents
More than 90 R&D specialists
9
| \$ l l S i i U m o n |
2 0 1 4 |
2 0 6 1 |
2 0 2 1 |
C G A R 1 4- 1 6 |
C G A R 1 6- 2 1 |
|---|---|---|---|---|---|
| l b l d l l i i i i G o a n o n- n a s e a n m n m a v v y |
|||||
| d l h i i i i t t t t t n v a s v e m e c a a e s e c r e a m e n |
|||||
| t s y s e m s |
6. 9 3 2 |
8. 4 3 7 |
1 3. 9 9 2 |
1 0 % |
1 1 % |
| b d E t t t t n e r g y a s e r e a m e n s y s e m s - |
2. 0 3 3 |
2. 6 0 7 |
4. 3 8 0 |
1 % 5 |
1 0 % |
| d h & k h B i S i i i t t o y s a p n g n g e n n g |
7 2 4 |
9 9 6 |
1. 9 6 5 |
% 1 7 |
% 1 5 |
| k S i j i t n r e e n a o n u v |
2 3 5 |
6 9 5 |
0 8 9 1. |
% 1 5 |
9 % |
| l H i a r r e m o v a |
3 5 3 |
3 4 1 |
3 3 3 |
-2 % |
0 % |
| i L t t t e g v e n r e a m e n s |
3 1 1 |
1 5 7 |
8 1 7 |
9 % |
% 4 |
| d A i t c n e r e u c o n |
9 6 |
1 1 0 |
1 2 5 |
7 % |
3 % |
| l i j i V t a g n a r e u v e n a o n |
n a |
1 0 5 |
3 3 2 |
n a |
% 2 6 |
| d l l P i i & t t t t g m e n e e s o n a o o r e m o v a |
8 0 |
9 9 |
1 4 2 |
1 1 % |
7 % |
| h O t e r |
1 2 6 |
1 6 7 |
2 0 7 |
% 1 5 |
% 4 |
| l T t o a |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
1 5 % |
1 0 % |
Source: Medical Insight Report
Reports n Reports' analysts forecast :Medical aesthetics market
2018 to 202310.6% CAGR
Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
"The global industrial laser market to grow at a CAGR of 10.24% during the period 2017-2021"
QUANTA - THUNDER MT (Blended Alexandrite + Yag) –High end system. The fastest in the world with scanner technology
DEKA - MOTUS AX and MOTUS AY – virtually pain free also on dark skin types, due to the Moveo Technology
ASCLEPION - NEW MEDIOSTAR with MONOLITH Handpiece 5kW diode -10 cm^2 - 20 Hz – single use Protector for the skin
2018 vs 2017: +19,4%
ASCLEPION – QuadroStarPRO YELLOW – 577 nm
Rembrandt's Syndrome
2018 vs 2017: +38,22%
Almost 2 GW of peak power (Pico)
18
DEKA - ONDA COOLWAVES – the first system in the world based on Microwaves @ 2,5 GHz for localized fat accumulations, laxity, and cellulite reduction
2018 vs 2017: +60,4%
Francesco Damiani – Boxing World Champion WBO – Super High Weights
ESTHELOGUE – B-STAR – the first system in the world based on stamp LED matrices for body treatments
#LASERFREE
DEKA – LUXEA – Just CE 0123 marked by TUV Sud
The most complete multiplatform with
Total :15 different handpieces
•
ASA LASER – M6 the only robotized system for pain removal
The multitarget Laser system was created to apply MLS® Laser Therapy automatically and uniformly to the treatment area.
TT® is the ultimate application of Hilterapia®, creating new and innovative possibilities in the treatment of painful pathologies of the musculoskeletal system.
2018 vs 2017: +14,0%
25
February 2019 - Hong Jinbao, the actor-symbol of Chinese cinema dedicated to martial arts flew to Taiwan to be treated with Hilterapia® in order to solve chronic knee pain
The most complete vaginal surgical multiplatform with:
Single use RF Touch Probe
UROLOGY - Stones Management and BPHHighlights
QUANTA – Litho 35 W Holmium laser QUANTA – Cyber Ho 60 W Holmium laser QUANTA – Cyber Ho 100 W Holmium laser ASCLEPION / JENA SURGICAL MultiPulse HoPLUS 140 W Holmium laser
with integrated morcellator
2018 vs 2017 : +51,6%
35 W
60 & 100 W
140 W
QUANTA – Virtual Stone Basket Effect – onboard of 100 W Holmium lasers to avoid stone retropulsionand to capture stone fragments
QUANTA – CYBER BLADE – CE 0123 mark expected for April 2019 – FDA 510(k) for September 2019
The only Stand Alone Morcellator working with batteries and single use blades – the fastest morcellationon the way
•Automatic CNC machines with up to 20 kW fiber lasers onboard
BEVELING CUT our new laser special preparation for butt-welding metal sheet edges
| '0 0 0 E u r o |
/ / 3 2 1 1 1 7 |
% | / / 3 2 8 1 1 1 |
% | % V a r. |
|---|---|---|---|---|---|
| d d i t u n a u e |
|||||
| d l i M e c a |
1 7 4 4 1 6 |
% 5 6 9 , |
1 9 7 8 5 4 |
% 5 7 2 , |
% 1 3 4 , |
| d l I i t n s r a u |
1 3 2 0 4 5 |
% 4 3 1 , |
1 4 8 1 6 7 |
% 4 2 8 , |
% 1 2 2 , |
| l T R t o a e v e n u e s |
3 0 6 6 1 4 |
1 0 0 0 % , |
3 6 0 2 0 4 |
1 0 0 0 % , |
1 2 9 % , |
| G i r o s s m a r g n |
1 2 2 8 4 7 |
4 1 % 5 , |
1 3 4 8 7 7 |
3 9 % 7 , |
8 0 % , |
| E B I T D A |
3 6 2 1 5 |
8 % 1 1 , |
3 6 8 5 1 |
0 3 % 1 , |
% 1 4 - , |
| E B I T |
3 0 9 4 4 |
9 9 % , |
2 9 9 8 7 |
8 % 7 , |
% 1 5 - , |
| P I t r e a x n c o m e |
2 7 2 1 7 |
% 8 9 , |
2 9 5 4 5 |
% 8 5 , |
% 8 6 , |
| i N t e n c o m e |
1 5 6 3 4 |
% 5 1 , |
1 6 7 9 4 |
% 4 9 , |
% 7 4 , |
| h I N t e n c o m e p e r s a r e |
0 8 1 , |
0 8 7 , |
|||
| '0 0 0 E u r o |
/ / 3 2 1 1 1 7 |
/ / 3 2 8 1 1 1 |
% V a r. |
|---|---|---|---|
| d d i t n a e u u |
|||
| l T t t t o a n o n c u r r e n a s s e s |
6 5 6 6 4 |
8 6 8 7 9 |
% 3 2 3 , |
| k l i i N W C t t e o r n g a p a |
6 3 6 2 2 |
9 9 0 7 7 |
2 6 % 5 , |
| f l N i i i i t t e n a n c a p o s o n |
8 4 5 0 6 |
6 2 4 6 1 |
2 6 1 % - , |
| l b l L i i i i t t o n g e r m a e s |
9 4 9 6 |
1 0 0 1 1 |
5 4 % , |
| i N E t t e q u y |
2 0 4 2 9 6 |
2 1 9 2 3 6 |
% 7 3 , |
| l l d i N t t e c a p a e m p o y e |
9 9 0 1 1 7 |
0 1 5 7 5 1 |
3 % 1 1 , |
| k l l N W i C i t t e o r n a p a o n s a e s g |
2 0 8 % , |
2 3 1 % , |
|
| R O C E |
2 5 4 % , |
1 9 1 % , |
|
| / ( ) l l d i E B I T N t t e c a p a e m p o y e |
|||
| C a p e x |
5 0 6 0 |
2 7 0 5 8 |
|
| 3 4 |
Wenzhou (2nd) – Penta Laser
| l l Eu i io ro m n |
|||||||
|---|---|---|---|---|---|---|---|
| l C a p e x p a n |
2 0 1 8 |
2 0 1 9 |
l T t o a |
||||
| l T t o a c a p e x |
2 7 |
1 2 |
3 9 |
||||
| f w h h: ic o l N t e w p a n s |
2 2 |
8 | 3 0 |
||||
| 3 8 |
39
| k h l d 's h i S E t t o c o e r q u y p e r s a r e |
1 0 4 , |
||
|---|---|---|---|
| / k l d i j. P B V A r c e o o a e u |
8 1 , |
||
| / ( ) E V E B I T 8 0 % E B I T |
1 2 2 , |
||
| / ( ) l l S 8 0 % S E V a e s a e s |
1 1 , |
||
| l. k C E E M t n a r e a p |
3 6 6 @ 7 , |
€ 9 0 0 1 , |
|
| f l i i i i N t t e n a n c a p o s o n |
6 2 @ 5 , |
/ / 3 2 8 1 1 1 |
|
| / l l i i i F t t t n a n c a n v e s m e n s m e r m |
2 3 @ 1 , |
/ / 3 2 8 1 1 1 |
|
| i l V E t n e r p r s e a u e |
2 9 1 9 , |
||
| 4 1 |
| Am nts ou |
in m ln |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| De 3 1s 2 0 1 8 t, c. / d ic l he ic M Ae t t e a s |
Pr ic e |
Re ve nu e |
Va % r. Re v. |
E B I T |
E B I T % |
M K. Ca p. |
E V |
/ le E V Sa s |
/ E V E B I T |
/ k P Bo o lu Va e |
| Cu te ra |
\$ 1 8, 3 3 |
\$ 1 6 3 |
7 % |
\$ ( ) 1 3 |
-8 % |
\$ 2 5 7 |
\$ 2 2 1 |
1, 4 |
n. a. |
5, 5 |
| ( ) isr d ic l S M 2 am e a |
\$ 0, 6 4 |
\$ 7 8 |
% 1 8 |
\$ 1 4 |
% 1 8 |
\$ 2 8 2 |
\$ 1 8 8 |
1, 2 |
6, 6 |
0, 9 |
| ic Lu tr on |
€ 8, 8 3 |
€ 7 1 |
6 % |
-€ 1 0 |
-1 5 % |
€ 2 2 0 |
€ 2 0 8 |
2, 9 |
n. a. |
2, 1 |
| du ia l In tr s |
||||||||||
| ho ic I P G P Co to n s |
\$ 1 5 1, 4 2 |
\$ 1. 4 6 0 |
4 % |
\$ 5 2 3 |
3 6 % |
\$ 7. 9 9 0 |
\$ 6. 9 4 9 |
4, 8 |
1 3, 3 |
3, 6 |
| im du ie Pr In tr a s |
€ 2 0, 8 5 |
€ 6 4 7 |
% 4 |
€ 2 8 |
6 % |
€ 2 9 1 |
€ 2 9 3 |
0, 6 |
0, 1 5 |
3 1, |
| 's Ha La n se r |
¥ 4 3, 3 8 |
¥ 1 1. 0 2 8 |
-5 % |
¥ 1. 8 1 7 |
1 6 % |
¥ 4 6. 2 9 0 |
¥ 4 6. 3 2 9 |
4, 2 |
2 5, 5 |
5, 1 |
| ( ) l. E En 1 |
€ 1 9, 0 0 |
€ 3 4 6 |
1 3 % |
€ 3 0 |
9 % |
€ 3 6 7 |
€ 2 9 2 |
1, 1 |
1 2, 2 |
1, 8 |
(1) EV and multiplies as for previous slide
(2) Data on June 30th, 2018
42
Nobel Prize for PhysicsProf. Géread Mourou
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected] MARONGIU [email protected]. +39 06-69923324
Contacts
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.